Please note that unsubscribing from medication reminders does not mean that you are unsubscribed from other emails that you are currently signed up to receive from Biogen.
Take this moment to learn about the VALOR Study, a clinical trial now enrolling people living with ALS caused by a genetic change (mutation) in the superoxide dismutase 1 (SOD1) gene. The clinical trial is evaluating the safety and potential efficacy of an investigational drug to see if it may help slow the progression of SOD1-ALS.
Potential study participants must:
Be 18 years of age or older
Have symptoms caused by ALS
Agree to genetic testing for the SOD1 mutation
Choosing to take part in a clinical trial is a big decision. It is important for you to understand what the trial is about, the potential risks, and what your participation would involve before agreeing to take part.
This link will take you away from a Biogen regulated website.